Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | 242.64 Thousand USD | -13.5% |
| 2021 | 280.51 Thousand USD | -37.02% |
| 2020 | 445.41 Thousand USD | -27.5% |
| 2019 | 614.34 Thousand USD | 35.5% |
| 2018 | 453.4 Thousand USD | 91.38% |
| 2017 | 236.91 Thousand USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 1.00 USD | -100.0% |
| 2014 | 266 Thousand USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 102 Thousand USD | 103.17% |
| 2011 | -3.21 Million USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 1.22 Million USD | -91.57% |
| 2008 | 14.48 Million USD | 30.97% |
| 2007 | 11.05 Million USD | 98.6% |
| 2006 | 5.56 Million USD | -27.7% |
| 2005 | 7.7 Million USD | 49.81% |
| 2004 | 5.14 Million USD | 38.21% |
| 2003 | 3.71 Million USD | -47.11% |
| 2002 | 7.03 Million USD | -54.86% |
| 2001 | 15.57 Million USD | -12.29% |
| 2000 | 17.75 Million USD | 33.92% |
| 1999 | 13.26 Million USD | 8.7% |
| 1998 | 12.2 Million USD | -15.28% |
| 1997 | 14.4 Million USD | 9.09% |
| 1996 | 13.2 Million USD | -21.89% |
| 1995 | 16.9 Million USD | 33.07% |
| 1994 | 12.7 Million USD | 43.18% |
| 1993 | 8.87 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 235.36 Thousand USD | -15.09% |
| 2023 Q1 | 277.17 Thousand USD | 14.23% |
| 2023 Q3 | 265.95 Thousand USD | 13.0% |
| 2022 Q2 | 243.62 Thousand USD | -16.36% |
| 2022 Q1 | 291.27 Thousand USD | 3.84% |
| 2022 Q4 | 242.64 Thousand USD | -11.33% |
| 2022 Q3 | 273.64 Thousand USD | 12.32% |
| 2022 FY | 242.64 Thousand USD | -13.5% |
| 2021 Q2 | 490.98 Thousand USD | 6.12% |
| 2021 Q4 | 280.51 Thousand USD | -0.09% |
| 2021 FY | 280.51 Thousand USD | -37.02% |
| 2021 Q1 | 462.67 Thousand USD | 3.87% |
| 2021 Q3 | 280.76 Thousand USD | -42.82% |
| 2020 Q2 | 690.07 Thousand USD | 6.04% |
| 2020 Q1 | 650.76 Thousand USD | 5.93% |
| 2020 Q3 | 690.4 Thousand USD | 0.05% |
| 2020 Q4 | 445.41 Thousand USD | -35.49% |
| 2020 FY | 445.41 Thousand USD | -27.5% |
| 2019 Q2 | 735.53 Thousand USD | 8.51% |
| 2019 Q1 | 677.85 Thousand USD | 49.51% |
| 2019 FY | 614.34 Thousand USD | 35.5% |
| 2019 Q4 | 614.34 Thousand USD | -10.81% |
| 2019 Q3 | 688.81 Thousand USD | -6.35% |
| 2018 Q4 | 453.4 Thousand USD | -31.57% |
| 2018 FY | 453.4 Thousand USD | 91.38% |
| 2018 Q2 | 727.28 Thousand USD | 189.72% |
| 2018 Q1 | 251.02 Thousand USD | 5.96% |
| 2018 Q3 | 662.53 Thousand USD | -8.9% |
| 2017 Q2 | 43.82 Thousand USD | 4382800.0% |
| 2017 Q1 | 1.00 USD | 0.0% |
| 2017 FY | 236.91 Thousand USD | 0.0% |
| 2017 Q4 | 236.91 Thousand USD | 221.32% |
| 2017 Q3 | 73.73 Thousand USD | 68.23% |
| 2016 Q3 | 1.00 USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2016 Q2 | 1.00 USD | 0.0% |
| 2016 FY | - USD | -100.0% |
| 2016 Q4 | - USD | -100.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | 1.00 USD | -100.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | 1.00 USD | 0.0% |
| 2014 Q4 | - USD | -100.0% |
| 2014 FY | 266 Thousand USD | 0.0% |
| 2014 Q1 | 266 Thousand USD | 0.0% |
| 2014 Q3 | 1.00 USD | -100.0% |
| 2014 Q2 | 138 Thousand USD | -48.12% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | -100.0% |
| 2013 Q1 | 1.00 USD | 100.0% |
| 2013 FY | - USD | -100.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | -3.03 Million USD | 0.0% |
| 2012 Q4 | -3.26 Million USD | -7.57% |
| 2012 FY | 102 Thousand USD | 103.17% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | -3.21 Million USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q2 | 1.3 Million USD | 7.21% |
| 2010 Q1 | 1.22 Million USD | -72.29% |
| 2010 Q4 | 1.19 Million USD | -15.0% |
| 2010 Q3 | 1.4 Million USD | 7.49% |
| 2009 Q1 | 14.48 Million USD | 2.98% |
| 2009 FY | 1.22 Million USD | -91.57% |
| 2009 Q2 | 14.97 Million USD | 3.4% |
| 2009 Q3 | 14.48 Million USD | -3.26% |
| 2009 Q4 | 4.4 Million USD | -69.57% |
| 2008 Q4 | 14.06 Million USD | 2.71% |
| 2008 Q2 | 11 Million USD | -0.43% |
| 2008 Q1 | 11.05 Million USD | -0.14% |
| 2008 Q3 | 13.69 Million USD | 24.35% |
| 2008 FY | 14.48 Million USD | 30.97% |
| 2007 FY | 11.05 Million USD | 98.6% |
| 2007 Q1 | 5.56 Million USD | -5.42% |
| 2007 Q2 | 8.64 Million USD | 55.2% |
| 2007 Q3 | 11.17 Million USD | 29.38% |
| 2007 Q4 | 11.07 Million USD | -0.96% |
| 2006 Q3 | 7.78 Million USD | 11.56% |
| 2006 Q1 | 7.7 Million USD | 4.48% |
| 2006 FY | 5.56 Million USD | -27.7% |
| 2006 Q2 | 6.97 Million USD | -9.43% |
| 2006 Q4 | 5.88 Million USD | -24.34% |
| 2005 Q2 | 5.95 Million USD | 15.89% |
| 2005 Q4 | 7.37 Million USD | 21.82% |
| 2005 Q1 | 5.14 Million USD | 0.74% |
| 2005 FY | 7.7 Million USD | 49.81% |
| 2005 Q3 | 6.05 Million USD | 1.56% |
| 2004 Q4 | 5.1 Million USD | 34.51% |
| 2004 Q2 | 3.45 Million USD | -7.04% |
| 2004 FY | 5.14 Million USD | 38.21% |
| 2004 Q1 | 3.71 Million USD | -24.32% |
| 2004 Q3 | 3.79 Million USD | 9.72% |
| 2003 Q1 | 7.03 Million USD | -5.75% |
| 2003 Q3 | 6.11 Million USD | -0.8% |
| 2003 FY | 3.71 Million USD | -47.11% |
| 2003 Q4 | 4.91 Million USD | -19.63% |
| 2003 Q2 | 6.16 Million USD | -12.36% |
| 2002 Q4 | 7.46 Million USD | -14.69% |
| 2002 Q1 | 15.57 Million USD | -10.06% |
| 2002 Q2 | 14.57 Million USD | -6.41% |
| 2002 FY | 7.03 Million USD | -54.86% |
| 2002 Q3 | 8.74 Million USD | -40.01% |
| 2001 Q4 | 17.32 Million USD | 0.64% |
| 2001 Q1 | 17.75 Million USD | 24.28% |
| 2001 Q2 | 16.91 Million USD | -4.74% |
| 2001 FY | 15.57 Million USD | -12.29% |
| 2001 Q3 | 17.21 Million USD | 1.73% |
| 2000 FY | 17.75 Million USD | 33.92% |
| 2000 Q3 | 14.61 Million USD | -2.06% |
| 2000 Q4 | 14.29 Million USD | -2.21% |
| 2000 Q2 | 14.92 Million USD | 12.51% |
| 2000 Q1 | 13.26 Million USD | -7.27% |
| 1999 FY | 13.26 Million USD | 8.7% |
| 1999 Q2 | 13.2 Million USD | 8.2% |
| 1999 Q3 | 14.6 Million USD | 10.61% |
| 1999 Q4 | 14.3 Million USD | -2.05% |
| 1999 Q1 | 12.2 Million USD | -11.59% |
| 1998 Q2 | 15.7 Million USD | 9.03% |
| 1998 Q4 | 13.8 Million USD | -6.76% |
| 1998 FY | 12.2 Million USD | -15.28% |
| 1998 Q1 | 14.4 Million USD | 8.27% |
| 1998 Q3 | 14.8 Million USD | -5.73% |
| 1997 FY | 14.4 Million USD | 9.09% |
| 1997 Q4 | 13.3 Million USD | -4.32% |
| 1997 Q1 | 13.2 Million USD | -2.94% |
| 1997 Q3 | 13.9 Million USD | -2.8% |
| 1997 Q2 | 14.3 Million USD | 8.33% |
| 1996 Q3 | 16.9 Million USD | 3.68% |
| 1996 Q4 | 13.6 Million USD | -19.53% |
| 1996 FY | 13.2 Million USD | -21.89% |
| 1996 Q1 | 16.9 Million USD | 2.42% |
| 1996 Q2 | 16.3 Million USD | -3.55% |
| 1995 Q4 | 16.5 Million USD | 9.34% |
| 1995 FY | 16.9 Million USD | 33.07% |
| 1995 Q3 | 15.09 Million USD | 6.64% |
| 1995 Q1 | 12.7 Million USD | 0.0% |
| 1995 Q2 | 14.15 Million USD | 11.42% |
| 1994 FY | 12.7 Million USD | 43.18% |
| 1993 FY | 8.87 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | 35.978% |
| Arrayit Corporation | 464.19 Thousand USD | 47.727% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | 67.946% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 10273.795% |
| DermTech, Inc. | 1 Million USD | 75.832% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 92.645% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 73.316% |
| iMD Companies, Inc. | 38.31 Thousand USD | -533.273% |
| IDenta Corp. | 442.28 Thousand USD | 45.138% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 80.225% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -48.739% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 69.05% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 64805.333% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | 48.238% |
| PharmChem, Inc. | 391.93 Thousand USD | 38.091% |
| Proteome Sciences plc | 1.06 Million USD | 77.227% |
| Response Genetics, Inc | 133 Thousand USD | -82.44% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -228.356% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -153.757% |
| Todos Medical Ltd. | 1.02 Million USD | 76.235% |